MK-2828
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 28, 2026
A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Chronic Kidney Disease • Nephrology • Renal Disease
February 28, 2026
A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)
(clinicaltrials.gov)
- P1 | N=28 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
New P1 trial
1 to 2
Of
2
Go to page
1